Patient outreach

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)